Nonobstructive Coronary Lesions and Ventricular Dysfunction

Many patients arrive to the cath lab for a diagnostic coronary angiography after an echo showing severe ventricular dysfunction, even in asymptomatic patients. In many occasions, their coronary arteries are normal, and in many others, we find coronary disease that is not enough to warrant such severe ventricular dysfunction.

Double Kissing Crush vs. Provisional Stenting

Patients with heart failure are frequently divided according to aetiology in ischemic and nonischemic. However, such binary classification combines patients with normal coronary arteries and patients with nonobstructive disease who might have a different prognosis.

This study divided patients with ventricular dysfunction into those with normal coronary arteries, nonobstructive disease, and obstructive disease.

The primary endpoint was a composite of cardiovascular death, nonfatal infarction, nonfatal stroke, and heart failure hospitalization.


Read also: The First Antidote Against Ticagrelor Is a Rapid-Acting, Extended Effect Agent in Preliminary Results.


Of 12,814 patients, 2656 (20.7%) had normal coronary arteries, 2254 (17.6%) had nonobstructive disease, and 7904 (61.7%) had obstructive disease.

The risk of the primary endpoint was significantly higher in the nonobstructive group (hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.04 to 1.32; p = 0.01) compared with the group with normal coronary arteries.


Read also: Patients: What They Really Want to Know about Their Disease.


Nonobstructive coronary artery disease was associated with an increase in cardiovascular death (HR: 1.82; 95% CI: 1.27 to 2.62; p = 0.001) and all-cause mortality (HR: 1.18; 95% CI: 1.05 to 1.33; p = 0.005). Still, there were no differences as regards acute myocardial infarction, stroke, or heart failure hospitalization.

Conclusion

Among patients with left ventricular dysfunction, the presence of nonobstructive coronary artery disease was independently associated with an increase in composite events and mortality.

Original title: Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.

Reference: Juarez R. Braga et al. J Am Coll Cardiol HF 2019, article in press.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....